Protocol Review and Monitoring Committee

The primary goal of the Protocol Review and Monitoring Committee (PRMC) is to ensure that institutional and industry-initiated cancer research studies involving human subjects conducted within the Washington University Medical Center are scientifically and statistically sound; appropriately designed; feasible for completion; and, if applicable, in compliance with National Institutes of Health guidelines for clinical trials, including monitoring for accrual and undue toxicity.

Joel Picus

Julie Margenthaler

Perry Grigsby


Camille Abboud

Kristan Augustin

Jeff Bradley

Caroline Bumb

Sara Butler

Traves Crabtree

Farrokh Dehdashti 

Gavin Dunn

Mark Fiala

Ryan Fields

Kathryn Fowler

Jennifer Frye

Karen Gauvain

Armin Ghobadi

Robert Hayashi

Richard Head

Meagan Jacoby

Sally Jones

Lisa Kehlenbrink

Albert Kim

A. Craig Lockhart

Lisa Madden

Russell Pachynski

John Pfeifer

Matthew Powell

Iskra Pusic

Lindsey Reichle

Cliff Robinson

Rizwan Romee

Anna Roshal

Kenneth B. Schechtman

Mark Schroeder

Karen Seibert

Joshua Shimony

Benjamin Tan

Wade Thorstad

Tom Walsh

Andrea Wang-Gillam

Saiama Waqar

Lorri DeWitt
Ad hoc

Lindsay Hladnik
Ad hoc

Lynne Lippmann
Ad hoc

Janelle Mann
Ad hoc

J. Philip Miller
Ad hoc

Sarah Moehlmann 
Ad hoc

Byron Peters 
Ad hoc

Chrisann Winslow
Ad hoc

Nancy Bartlett
Ex officio

Jeff Michalski
Ex officio

Jeffrey Moley
Ex officio

Stephen Ristvedt
Ex officio

Barry Siegel
Ex officio

BSS membership

Aimee James

Teresa Deshields

Anjali Deshpande

Bettina Drake

Donna Jeffe

Allison King

Amy McQueen

Yikyung Park

Tanya Wildes

Phil Miller 


Last updated 8/28/2014